Literature DB >> 11152384

Investigations into the mechanism of 2,3-dimercaptopropanol neurotoxicity.

C W Nogueira1, F A Soares, R C Bolzan, M C Jacques-Silva, D O Souza, J B Rocha.   

Abstract

2,3 dimercaptopropanol (BAL), is a dithiol chelating agent, used for the treatment of heavy metal intoxication; however, this compound has low therapeutic efficacy and in some situations may cause neurotoxic effects. In experimental models, administration of high doses of BAL produces seizures that culminate in animal death. However, investigations on the modulation of neurotransmitter system(s) involved in BAL-induced seizures are still lacking in the literature. In the present study, the neurotoxicity of BAL, as measured by the manifestation of seizures was examined and the modulation of glutamatergic and GABAergic receptors and ion channels potentially involved in BAL-induced seizures was investigated. The results demonstrated that BAL (18.6 mg/kg) induced seizures and all mice died within one day. GABAergic allosteric modulators (3 or 12 mg/kg diazepam and 50 mg/kg phenobarbital) blocked the appearance of seizure and reduced almost completely the death caused by BAL. Carbamazepine (5 mg/kg) significantly reduced the incidence of BAL-induced seizures, while sodium valproate and MK-801 were not effective in reducing the incidence of seizures. Valproate (300 mg/kg) and MK-801(0.5 mg/kg) prolonged the latencies for onset of seizures; however, all animals died within one day after BAL administration. High doses of ZnCl2 (135 mg/kg) blocked the appearance of seizures episodes, but no animal survived more than one day. The content of total non-protein -SH in brain of mice treated with 18.6 and 124 mg/kg BAL increased from 0.9+/-0.3 nmol/g (control animals) to 1.7+/-0.3 and 3.5+/-0.8 nmol/g, respectively. In vitro, 0.1-1 mM concentrations of BAL inhibited [3H]glutamate and [3H]MK-801 binding, but increased the binding of [3H]muscimol to brain synaptic plasma membrane. The results reported here demonstrate that GABAergic allosteric modulators (diazepam and phenobarbital) and carbamazepine, a compound that acts by prolonging the recovery of voltage-activated ion channels from inactivation, are able to abolish BAL-induced seizures, while the NMDA antagonist (MK-801) prolonged the latencies for onset of seizures suggesting that modulators of this subtype of glutamate receptor have a modest role on BAL-induced seizures. The results of the present study suggest that allosteric modulators of GABAergic system and carbamazepine, a voltage-gated Na+-channel antagonist, should be considered for the treatment of animals or patients intoxicated with BAL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11152384     DOI: 10.1023/a:1026658217907

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  48 in total

Review 1.  The pharmacology of mercury compounds.

Authors:  T W Clarkson
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

2.  Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation.

Authors:  D H Jones; A I Matus
Journal:  Biochim Biophys Acta       Date:  1974-08-09

Review 3.  Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.

Authors:  H S White
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

4.  Ca2+ channel blockade and the antielectroshock activity of NMDA receptor antagonists, CGP 40116 and CGP 43487, in mice.

Authors:  M Gasior; K Borowicz; R Starownik; Z Kleinrok; S J Czuczwar
Journal:  Eur J Pharmacol       Date:  1996-09-19       Impact factor: 4.432

5.  Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons.

Authors:  G L Westbrook; M L Mayer
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

6.  Guanosine and GMP prevent seizures induced by quinolinic acid in mice.

Authors:  A P Schmidt; D R Lara; J de Faria Maraschin; A da Silveira Perla; D Onofre Souza
Journal:  Brain Res       Date:  2000-05-02       Impact factor: 3.252

7.  Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors.

Authors:  E X Albuquerque; E F Pereira; M F Braga; M Alkondon
Journal:  J Physiol Paris       Date:  1998 Jun-Aug

8.  delta-Aminolevulinate dehydratase inhibition by 2,3-dimercaptopropanol is mediated by chelation of zinc from a site involved in maintaining cysteinyl residues in a reduced state.

Authors:  T Emanuelli; J B Rocha; M E Pereira; P C Nascimento; D O Souza; F A Beber
Journal:  Pharmacol Toxicol       Date:  1998-09

Review 9.  Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

10.  A possible role of glutathione as an endogenous agonist at the N-methyl-D-aspartate recognition domain in rat brain.

Authors:  K Ogita; R Enomoto; F Nakahara; N Ishitsubo; Y Yoneda
Journal:  J Neurochem       Date:  1995-03       Impact factor: 5.372

View more
  3 in total

1.  Effect of dithiol chelating agents on [3H]MK-801 and [3H]glutamate binding to synaptic plasma membranes.

Authors:  C W Nogueira; J B Rocha; D O Souza
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

2.  2,3-Dimercaptopropanol inhibits Ca2+ transport in microsomes from brain but not from fast-skeletal muscle.

Authors:  E B Quinhones; D O Souza; J B Rocha
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

3.  Interaction between metals and chelating agents affects glutamate binding on brain synaptic membranes.

Authors:  Félix Antunes Soares; Marcelo Farina; Francielli Weber Santos; Diogo Souza; João Batista Teixeira Rocha; Cristina Wayne Nogueira
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.